Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical Transplants|August 7, 2014
The differential pathogenicity of HLA antibodies: what a large cross-sectional study can tell usNils Lachmann, Constanze Schönemann
Clinical Transplants|March 28, 2008
Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-upNils Lachmann, Paul I Terasaki, Constanze Schönemann
Transplantation|January 29, 2013
Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodiesNils Lachmann, Kremena Todorova, Harald Schulze, et al.
Cytometry. Part B, Clinical Cytometry|October 12, 2004
Flow cytometric detection of complement-activating HLA antibodiesConstanze Schönemann, Nils Lachmann, Holger Kiesewetter, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|August 8, 2013
Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusionNils Lachmann, Kremena Todorova, Harald Schulze, et al.
Clinical Transplants|June 8, 2010
Antihumoral rejection therapy by proteasome inhibitor bortezomib: a case seriesNils Lachmann, Manuela Schütz, Klemens Budde, et al.
Transplantation|July 23, 2009
Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failureJunchao Cai, Paul I Terasaki, Naomi Anderson, et al.
Journal of Immunology Research|March 4, 2017
Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by StepNils Lachmann, Michael Duerr, Constanze Schönemann, et al.
Transplantation|January 17, 2002
Soluble CD30 as a predictor of kidney graft outcomeSteffen Pelzl, Gerhard Opelz, Manfred Wiesel, et al.
Pageof 4